The nation of Zimbabwe has declined a significant US healthcare agreement worth $367m (272 million pounds) spanning five years because of the United States' insistence on confidential data.
This move came to light following a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesman later clarified that the US was seeking genetic material for research and commercial gain while was not willing to share the benefits from any future vaccines.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for further dialogue to reach a agreement suitable to all parties so the nation's critical HIV treatment initiative can proceed.
Wider Context
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court blocked a related health funding agreement following legal challenges were filed about the security of Kenyans' health data.
After returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.
According to reports, 16 African countries have so far signed these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information for a long time, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that might result from that provided information," Mangwana explained.
"In essence, our nation would provide the raw materials for medical research without any assurance that the final treatments would be accessible to our population if a future disease outbreak arise."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were upending systems previously established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a country provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."
These objections regarding the US deal "are not meant as hostility towards the US," he added.
"We welcome further dialogue with our US partners on how subsequent co-operation might be arranged in a way that honours the independence and interests of both nations."
Health Experts Response
A leading public health body said it recognised the official position, but recommended that talks should continue given that a large portion of the country's HIV programmes relied on external financing.
"Where specific concerns arise, including those involving data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group commented.
This impasse emphasises the complex tensions between accepting vital foreign assistance and protecting a country's data in an increasingly interconnected world.